Schedule 13G ownership disclosure

GLOBAL BLOOD THERAPEUTICS INC

Security class unavailable · CUSIP: 37890U108

Event date: 2016-12-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,095,129
Percent of class
5.6100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-17-000173
Form type
SC 13G
Filer
Global Blood Therapeutics, Inc.
CIK
CIK 1629137
Filed
Feb 09, 2017
Reporting period
Dec 30, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub